Bristol-Myers Squibb Company BMY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score

56/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Bristol-Myers Squibb Company (BMY), dont 29 achats et 21 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $2.99M.

Les initiés notables ayant une activité récente comprennent Elkins David V, Shanahan Karin, Yale Phyllis R. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — BMY

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Elkins David V	EVP, Chief Financial Officer	Vente Informative	4,481	$62.05	$278.05K	159,248
2026-04-01	Shanahan Karin	EVP, Chief Supply Chain & Ops	Exercice d'Options (Vente)	3,307	-	-	-
2026-03-31	Yale Phyllis R	Director	Attribution de RSU	577	-	-	43,904
2026-03-31	Arduini Peter J	Director	Attribution de RSU	577	-	-	71,435
2026-03-31	Rice Derica W	Director	Attribution de RSU	639	-	-	39,964
2026-03-31	Mcmullen Michael R.	Director	Attribution de RSU	577	-	-	15,557
2026-03-31	Samuels Theodore R. Ii	Director	Attribution de RSU	845	-	-	68,728
2026-03-10	Elkins David V	EVP, Chief Financial Officer	Exercice d'Options (Vente)	7,654	-	-	-
2026-03-10	Boerner Christopher S.	Chief Executive Officer	Exercice d'Options (Vente)	6,618	-	-	-
2026-03-10	Hickey Benjamin	President, Rayzebio Org.	Attribution de RSU	11,429	-	-	11,429
2026-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercice d'Options (Vente)	1,107	-	-	-
2026-03-10	Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Exercice d'Options (Vente)	19,760	-	-	-
2026-03-10	Shanahan Karin	EVP, Chief Supply Chain & Ops	Exercice d'Options (Vente)	19,760	-	-	-
2026-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercice d'Options (Vente)	8,241	-	-	-
2026-03-10	Gallman Cari	EVP, General Counsel	Exercice d'Options (Vente)	5,201	-	-	-
2026-03-10	Poole Ahn Amanda	EVP, Chief People Officer	Exercice d'Options (Vente)	4,822	-	-	-
2026-03-10	Hoch Lynelle	President, Cell Therapy Org.	Exercice d'Options (Vente)	6,304	-	-	-
2026-03-10	Holzer Phil M	SVP and Controller	Exercice d'Options (Vente)	811	-	-	-
2026-03-10	Short Bartie Wendy	EVP, Corporate Affairs	Exercice d'Options (Vente)	639	-	-	-
2026-03-10	Shibutani Hiroshi Chris	EVP, Chief Strategy Officer	Attribution de RSU	7,837	-	-	7,837
2026-03-10	Massacesi Cristian	EVP,chief Med Offr,head of Dev	Attribution de RSU	26,122	-	-	26,122
2026-02-01	Yale Phyllis R	Director	Attribution de RSU	3,996	-	-	43,327
2026-02-01	Arduini Peter J	Director	Attribution de RSU	3,996	-	-	70,858
2026-02-01	Rice Derica W	Director	Attribution de RSU	3,996	-	-	39,325
2026-02-01	Price Paula A	Director	Attribution de RSU	3,996	-	-	25,498
2026-02-01	Mcmullen Michael R.	Director	Attribution de RSU	3,996	-	-	14,980
2026-02-01	Haller Julia A	Director	Attribution de RSU	3,996	-	-	37,903
2026-02-01	Samuels Theodore R. Ii	Director	Attribution de RSU	3,996	-	-	67,883
2026-02-01	Vousden Karen H	Director	Attribution de RSU	3,996	-	-	41,069
2026-02-01	Hickey Benjamin	President, Rayzebio Org.	Exercice d'Options (Vente)	10,079	-	-	10,079
2026-02-01	Hidalgo Medina Manuel	Director	Attribution de RSU	3,996	-	-	22,764
2026-02-01	Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Exercice d'Options (Vente)	2,543	-	-	-
2026-02-01	Bhatt Deepak	Director	Attribution de RSU	3,996	-	-	19,242
2025-12-31	Yale Phyllis R	Director	Attribution de RSU	649	-	-	38,892
2025-12-31	Arduini Peter J	Director	Attribution de RSU	626	-	-	66,116
2025-12-31	Rice Derica W	Director	Attribution de RSU	695	-	-	34,935
2025-12-31	Mcmullen Michael R.	Director	Attribution de RSU	649	-	-	10,861
2025-12-31	Samuels Theodore R. Ii	Director	Attribution de RSU	927	-	-	63,174
2025-11-03	Lenkowsky Adam	EVP, Chief Commercial Officer	Attribution de RSU	22,568	-	-	22,568
2025-11-01	Boerner Christopher S.	Chief Executive Officer	Retenue Fiscale RSU	1,238	$46.07	$57.03K	1,182
2025-11-01	Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Exercice d'Options (Vente)	6,281	-	-	12,562
2025-11-01	Shanahan Karin	EVP, Chief Supply Chain & Ops	Exercice d'Options (Vente)	6,281	-	-	12,562
2025-10-02	Gallman Cari	EVP, General Counsel	Exercice d'Options (Vente)	4,558	-	-	4,559
2025-09-30	Yale Phyllis R	Director	Attribution de RSU	776	-	-	37,735
2025-09-30	Arduini Peter J	Director	Attribution de RSU	748	-	-	64,620
2025-09-30	Rice Derica W	Director	Attribution de RSU	831	-	-	33,784
2025-09-30	Mcmullen Michael R.	Director	Attribution de RSU	776	-	-	10,076
2025-09-30	Samuels Theodore R. Ii	Director	Attribution de RSU	1,109	-	-	61,420
2025-09-02	Elkins David V	EVP, Chief Financial Officer	Vente Informative	56,000	$47.33	$2.65M	167,379
2025-09-01	Short Bartie Wendy	EVP, Corporate Affairs	Exercice d'Options (Vente)	1,235	-	-	1,236

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration